NVIV - InVivo Therapeutics Holdings Corp.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201712/31/201612/31/201512/31/2014
Net Income-26,745-23,438-33,314-18,346
Operating Activities, Cash Flows Provided By or Used In
Depreciation395548684752
Adjustments To Net Income6,6024,78115,6763,756
Changes In Accounts Receivables----
Changes In Liabilities-23489-48-330
Changes In Inventories----
Changes In Other Operating Activities88880673-1,116
Total Cash Flow From Operating Activities-19,683-16,740-16,329-15,284
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-65-107-5-47
Investments11,577-6,401-5,274-5,274
Other Cash flows from Investing Activities---45
Total Cash Flows From Investing Activities11,512-6,508-5,279-2
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock8030,18723,33714,842
Net Borrowings-423-395-268-77
Other Cash Flows from Financing Activities-40-40-40-40
Total Cash Flows From Financing Activities-38329,79223,06914,765
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents-8,5546,5441,461-521